07756 859468

Dr Elizabeth Bird-Lieberman

Consultant Gastroenterologist
MB BChir, PhD Cantab, FRCP

Dr Elizabeth Bird-Lieberman

Member of Doctify

Dr Elizabeth Bird-Lieberman (MB BChir, PhD Cantab, FRCP) is a Consultant Gastroenterologist at Oxford University Hospitals NHS Foundation Trust and Nuffield Health, The Manor Hospital, Oxford with more than 25 years of experience. Alongside her work in general gastroenterology, she has a specialist interest in the early detection and prevention of gastrointestinal cancers. She is a clinical specialist in advanced diagnostic and therapeutic endoscopy and a nationally accredited Bowel Cancer Screening colonoscopist.

Dr Bird-Lieberman graduated from the University of Cambridge in 2000. During her training in General Internal Medicine and Gastroenterology, she completed a PhD at the University of Cambridge in 2010. Her doctoral research focused on the early detection of oesophageal cancer through molecular imaging in endoscopy and biomarker development. Following completion of her specialist training, she was appointed Clinical Lecturer in Translational Medicine and Therapeutics in Cambridge before taking up her consultant post at Oxford University Hospitals in 2013. She is an Honorary Senior Clinical Lecturer at the University of Oxford.

Her research on early cancer detection has been funded by major funding bodies including the Medical Research Council, Cancer Research UK, the Academy of Medical Sciences, the Wellcome Trust and the National Institute for Health Research. She has published widely in high-impact peer-reviewed journals.

Nationally, Dr Bird-Lieberman serves as the Guideline Lead for the British Society of Gastroenterology, ensuring the production of high quality guidelines based on evidence to improve the national quality of care in gastroenterology. She is Associate Editor for the journal Gut, one of the most relevant journals in gastroenterology worldwide. She is a key member of the British Society of Gastroenterology Clinical Services Committee which has a remit to advance excellent patient care by improving service delivery and encouraging quality improvement. She has a passion for teaching. She is a nationally recognised trainer in endoscopy and she leads the Gastroenterology teaching for the medical students on the University of Oxford Graduate Entry Medical School.

Dr Bird-Lieberman is committed to providing the highest quality, evidence based care undertaken with an empathic and holistic approach. She focuses on clear communication. Alongside traditional medical management she recognises the importance of lifestyle and nutritional aspects in her patients' care. This always includes a focus on preventive medicine and keeping her patients as fit as possible for the future.

Her expertise in endoscopy means she makes these procedures more comfortable for the patient while maintaining safety and the most excellent quality.

 

Links:

Selected Publications:

  1. Setting a vision for British Society of Gastroenterology guidelines: embracing innovation while preserving methodological excellence and clinical utility. Kurien M, Bird-Lieberman E, Din S, Gordon H, Lamb CA, Rees CJ. Gut. 2025 Sep 18:gutjnl-2025-336942.
  2. Biopsy Sampling in Upper Gastrointestinal Endoscopy: A Survey from 10 Tertiary Referral Centres Across Europe. Bornschein J, Tran-Nguyen T, Fernandez-Esparrach G, Ash S, Balaguer F, Bird-Lieberman EL, Córdova H, Dzerve Z, Fassan M, Leja M, Lyutakov I, Middelburg T, Moreira L, Nakov R, Nieuwenburg SAV, O'Connor A, Realdon S, De Schepper H, Smet A, Spaander MCW, Tolmanis I, Urbonas T, Weigt J, Hold GL, Link A, Kupcinskas J; ENIGMA: European Network for the Investigation of Gastrointestinal Mucosal Alterations. Dig Dis. 2021;39(3):179-189.
  3. Blue Light Imaging and Linked Color Imaging for the Characterization of Mucosal Changes in Chronic Gastritis: A Clinicians View and Brief Technical Report. Weigt J, Malfertheiner P, Canbay A, Haybaeck J, Bird-Lieberman E, Link A. Dig Dis. 2020;38(1):9-14.
  4. The Rationale and Efficacy of Primary and Secondary Prevention in Adenocarcinomas of the Upper Gastrointestinal Tract. Bornschein J, Bird-Lieberman EL, Malfertheiner P. Dig Dis. 2019;37(5):381-393
  5. Diminutive polyps and future colorectal cancer risk perception: how low do we need to go? Bird-Lieberman E, East JE. Endoscopy. 2018 Mar;50(3):197-199.
  6. Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus. Bird-Lieberman EL, Neves AA, O'Donovan M, Lao-Sirieix P, Lovat L, Eng WS, Mahal LK, Brindle KM and Fitzgerald RC. Nature Medicine 2012; 15;18(2):315-21.
  7. Population-Based Study Reveals New Risk-Stratification Biomarker Panel for Barrett's Esophagus. Bird-Lieberman EL, Dunn J, Coleman HG, Lao-Sirieix P, Oukrif D, Moore CE, Varghese S, Johnston B, Arthur K, McManus D, Novelli MR, O’Donoven M, Cardwell CR, Lovat LB, Murray LJ and Fitzgerald RC. Gastroenterology 2012; 143(4): 927-935.
  8. Randomized crossover study comparing efficacy of transnasal endoscopy with that of standard endoscopy to detect Barrett's esophagus. Bird-Lieberman EL, Shariff K, O’Donovan M, Abdullahi Z, Liu X, Blazeby J and Fitzgerald RC. Gastrointest Endosc. 2012; 75(5):954-61.
  9. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, Trudgill N, Patel P, Kaye PV, Sanders S, O'Donovan M, Bird-Lieberman EL, Bhandari P, Jankowski JA, Attwood S, Parsons SL, Loft D, Lagergren J, Moayyedi P, Lyratzopoulos G and de Caestecker J. Gut 2014; 63(1): 7-42.
  10. Electronic imaging to enhance lesion detection at colonoscopy. Ket SN, Bird-Lieberman E, East JE. Gastrointest Endosc Clin N Am. 2015 Apr;25(2):227-42.
  11. Autofluorescence-Directed Confocal Endomicroscopy in Combination With a Three-Biomarker Panel Can Inform Management Decisions in Barrett's Esophagus. di Pietro M, Bird-Lieberman EL, Liu X, Nuckcheddy-Grant T, Bertani H, O'Donovan M, Fitzgerald RC. Am J Gastroenterol. 2015 Sep 29. doi: 10.1038/ajg.2015.295.
  12. MMP2 and MMP7 at the invasive front of gastric cancer are not associated with mTOR expression. Bornschein J, Seidel T, Langner C, Link A, Wex T, Selgrad M, Jechorek D, Meyer F, Bird-Lieberman E, Vieth M, Malfertheiner P. Diagn Pathol. 2015 Dec 12; 10:212. doi: 10.1186/s13000-015-0449-z.
  13. Diminutive polyps and future colorectal cancer risk perception: how low do we need to go? Bird-Lieberman E and East JE. Endoscopy. 2018 Mar;50(3):197-199. doi: 10.1055/s-0044-100493.
  14. The Rationale and Efficacy of Primary and Secondary Prevention in Adenocarcinomas of the Upper Gastrointestinal Tract. Bornschein J, Bird-Lieberman EL, Malfertheiner P. Dig Dis. 2019;37(5):381-393. doi: 10.1159/000499706.
  15. Blue Light Imaging and Linked Color Imaging for the Characterization of Mucosal Changes in Chronic Gastritis: A Clinicians View and Brief Technical Report. Weigt J, Malfertheiner P, Canbay A, Haybaeck J, Bird-Lieberman E, Link A. Dig Dis. 2019 Jul 23:1-6. doi: 10.1159/000501265.